Molecular Immunology and Tumor Biology View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

1978-2021

FUNDING AMOUNT

6510216 USD

ABSTRACT

? DESCRIPTION (provided by applicant): This T32 Training Grant has for more than three decades focused on the successful training of research-oriented pathologist-scientists and other basic scientists in the MGH Pathology department. Over the past two five-year funding periods, trainees have published a considerable number of papers, including many in high quality journals, and have competed successfully faculty positions in prestigious universities and medical schools and for research-focused positions in industry. The mentors of this current proposal comprise 29 Harvard and Massachusetts Institute of Technology faculty who are primarily centered in the Massachusetts General Hospital Pathology department and Cancer Center. This interactive, overlapping community of scientists and physician- scientists is organized into thematic programs that include: cancer genetics; cancer epigenetics; animal models of cancer; RNA biology; tissue, cell, and genome engineering technologies; cell cycle control and DNA damage repair; stem cell biology; immunology and chemical biology; and in vivo imaging for cancer biology and diagnosis. As in previous cycles, the trainees will be selected from a highly competitive pool of MD, MD-PhD and PhD applicants on the basis of prior academic and research achievements and evidence of a strong commitment to a career in cancer biology. The period of training will be two or three years for each successful applicant. An active and program- specific recruitment and retention program to enhance diversity ensures that diverse applicants have access to, and will succeed in, the training program. In summary, the proposed T32 program renewal capitalizes on a highly interactive, experienced and focused faculty; a distinguished record of training productive physicians and scientists, including underrepresented minorities; state-of-the-art facilities and educational resources; and exposure of the trainees to basic and translational aspects of cancer biology. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=9512692

Related SciGraph Publications

  • 2019-01-14. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair in NATURE NEUROSCIENCE
  • 2018-12. TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations in ACTA NEUROPATHOLOGICA COMMUNICATIONS
  • 2018-12. Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients in ACTA NEUROPATHOLOGICA COMMUNICATIONS
  • 2018-08. An enhanced CRISPR repressor for targeted mammalian gene regulation in NATURE METHODS
  • 2018-05-21. High-throughput creation and functional profiling of DNA sequence variant libraries using CRISPR–Cas9 in yeast in NATURE BIOTECHNOLOGY
  • 2018-01. A CRISPR–Cas9-based gene drive platform for genetic interaction analysis in Candida albicans in NATURE MICROBIOLOGY
  • 2017-04. Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform in NATURE MICROBIOLOGY
  • 2016-10-31. Monitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging in NATURE COMMUNICATIONS
  • 2016-07. Comparison of Cas9 activators in multiple species in NATURE METHODS
  • 2015-12. Safeguarding CRISPR-Cas9 gene drives in yeast in NATURE BIOTECHNOLOGY
  • 2015-11. Cas9 gRNA engineering for genome editing, activation and repression in NATURE METHODS
  • 2015-07. Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage in NATURE BIOTECHNOLOGY
  • 2015-04. Highly efficient Cas9-mediated transcriptional programming in NATURE METHODS
  • 2014-08. Oncogenic RIT1 mutations in lung adenocarcinoma in ONCOGENE
  • 2014-08. Stem cell aging: mechanisms, regulators and therapeutic opportunities in NATURE MEDICINE
  • 2013-11. Differential regulation of myeloid leukemias by the bone marrow microenvironment in NATURE MEDICINE
  • 2013-08. Signatures of mutational processes in human cancer in NATURE
  • 2013-07. Mutational heterogeneity in cancer and the search for new cancer-associated genes in NATURE
  • 2013-03. Robust, synergistic regulation of human gene expression using TALE activators in NATURE METHODS
  • 2013-01. TALENs: a widely applicable technology for targeted genome editing in NATURE REVIEWS MOLECULAR CELL BIOLOGY
  • 2012-06. mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake in NATURE
  • 2012-05. FLASH assembly of TALENs for high-throughput genome editing in NATURE BIOTECHNOLOGY
  • 2012-03. A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response in NATURE CELL BIOLOGY
  • 2011-12. ZFNGenome: A comprehensive resource for locating zinc finger nuclease target sites in model organisms in BMC GENOMICS
  • 2011-08. Targeted gene disruption in somatic zebrafish cells using engineered TALENs in NATURE BIOTECHNOLOGY
  • 2011-03. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA in NATURE
  • 2011-02. High-throughput imaging of adult fluorescent zebrafish with an LED fluorescence macroscope in NATURE PROTOCOLS
  • 2011-01. Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA) in NATURE METHODS
  • 2010-12. Predicting success of oligomerized pool engineering (OPEN) for zinc finger target site sequences in BMC BIOINFORMATICS
  • 2008-11. FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway in NATURE STRUCTURAL & MOLECULAR BIOLOGY
  • 2008-05. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) in NATURE GENETICS
  • 2007-08. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells in NATURE
  • 2006-08. Standardized reagents and protocols for engineering zinc finger nucleases by modular assembly in NATURE PROTOCOLS
  • 2003-07. Radiation hybrid mapping of the canine type I and type IV collagen gene subfamilies in FUNCTIONAL & INTEGRATIVE GENOMICS
  • 1993-05. Role of Integrin α2β1 (VLA-2) in the Migration of Human Melanoma Cells on Laminin and Type IV Collagen in JOURNAL OF INVESTIGATIVE DERMATOLOGY
  • 1982-09. Reduction of the Fraction of Circulating Helper-Induced T Cells Identified by Monoclonal Antibodies in Psoriatic Patients Treated with Long-term Psoralen/Ultraviolet-A Radiation (PUVA) in JOURNAL OF INVESTIGATIVE DERMATOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2206", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "USD", 
          "type": "MonetaryAmount", 
          "value": "6510216"
        }, 
        "description": "? DESCRIPTION (provided by applicant): This T32 Training Grant has for more than three decades focused on the successful training of research-oriented pathologist-scientists and other basic scientists in the MGH Pathology department. Over the past two five-year funding periods, trainees have published a considerable number of papers, including many in high quality journals, and have competed successfully faculty positions in prestigious universities and medical schools and for research-focused positions in industry. The mentors of this current proposal comprise 29 Harvard and Massachusetts Institute of Technology faculty who are primarily centered in the Massachusetts General Hospital Pathology department and Cancer Center. This interactive, overlapping community of scientists and physician- scientists is organized into thematic programs that include: cancer genetics; cancer epigenetics; animal models of cancer; RNA biology; tissue, cell, and genome engineering technologies; cell cycle control and DNA damage repair; stem cell biology; immunology and chemical biology; and in vivo imaging for cancer biology and diagnosis. As in previous cycles, the trainees will be selected from a highly competitive pool of MD, MD-PhD and PhD applicants on the basis of prior academic and research achievements and evidence of a strong commitment to a career in cancer biology. The period of training will be two or three years for each successful applicant. An active and program- specific recruitment and retention program to enhance diversity ensures that diverse applicants have access to, and will succeed in, the training program. In summary, the proposed T32 program renewal capitalizes on a highly interactive, experienced and focused faculty; a distinguished record of training productive physicians and scientists, including underrepresented minorities; state-of-the-art facilities and educational resources; and exposure of the trainees to basic and translational aspects of cancer biology.", 
        "endDate": "2021-06-30T00:00:00Z", 
        "funder": {
          "id": "https://www.grid.ac/institutes/grid.48336.3a", 
          "type": "Organization"
        }, 
        "id": "sg:grant.2682506", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "2682506"
            ]
          }, 
          {
            "name": "nih_id", 
            "type": "PropertyValue", 
            "value": [
              "T32CA009216"
            ]
          }
        ], 
        "inLanguage": [
          "en"
        ], 
        "keywords": [
          "high quality journals", 
          "period", 
          "faculty positions", 
          "previous cycle", 
          "scientists", 
          "current proposals", 
          "underrepresented minorities", 
          "translational aspects", 
          "successful training", 
          "cell cycle control", 
          "program- specific recruitment", 
          "tumor biology", 
          "cancer genetics", 
          "successful applicants", 
          "MD", 
          "description", 
          "T32 training grant", 
          "years", 
          "Massachusetts Institute", 
          "applicants", 
          "mentors", 
          "community", 
          "chemical biology", 
          "Molecular Immunology", 
          "MGH Pathology department", 
          "art facilities", 
          "strong commitment", 
          "Harvard", 
          "cancer", 
          "decades", 
          "training", 
          "stem cell biology", 
          "productive physicians", 
          "immunology", 
          "basis", 
          "cells", 
          "research achievements", 
          "diversity", 
          "medical school", 
          "other basic scientists", 
          "vivo imaging", 
          "Technology Faculty", 
          "genome engineering technologies", 
          "summary", 
          "trainees", 
          "RNA biology", 
          "competitive pool", 
          "diagnosis", 
          "paper", 
          "research", 
          "industry", 
          "cancer epigenetics", 
          "retention programs", 
          "five-year funding periods", 
          "considerable number", 
          "distinguished record", 
          "Massachusetts General Hospital Pathology department", 
          "PhD applicants", 
          "DNA damage repair", 
          "tissue", 
          "access", 
          "position", 
          "pathologist-scientists", 
          "educational resources", 
          "diverse applicants", 
          "career", 
          "cancer center", 
          "physician- scientists", 
          "thematic program", 
          "MD-PhD", 
          "training program", 
          "focused faculty", 
          "exposure", 
          "prestigious universities", 
          "evidence", 
          "state", 
          "animal models", 
          "cancer biology", 
          "T32 program renewal"
        ], 
        "name": "Molecular Immunology and Tumor Biology", 
        "recipient": [
          {
            "id": "https://www.grid.ac/institutes/grid.32224.35", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.32224.35", 
              "name": "MASSACHUSETTS GENERAL HOSPITAL", 
              "type": "Organization"
            }, 
            "familyName": "JOUNG", 
            "givenName": "J. KEITH", 
            "id": "sg:person.0667170477.75", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.0667170477.75", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.2682506"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2019-03-07T12:07", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_19.xml.gz", 
        "startDate": "1978-09-30T00:00:00Z", 
        "type": "MonetaryGrant", 
        "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9512692"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2682506'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2682506'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2682506'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2682506'


     

    This table displays all metadata directly associated to this object as RDF triples.

    123 TRIPLES      19 PREDICATES      101 URIs      93 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.2682506 schema:about anzsrc-for:2206
    2 schema:amount N861e84ff7c7a41b9948798cddf3c4f89
    3 schema:description ? DESCRIPTION (provided by applicant): This T32 Training Grant has for more than three decades focused on the successful training of research-oriented pathologist-scientists and other basic scientists in the MGH Pathology department. Over the past two five-year funding periods, trainees have published a considerable number of papers, including many in high quality journals, and have competed successfully faculty positions in prestigious universities and medical schools and for research-focused positions in industry. The mentors of this current proposal comprise 29 Harvard and Massachusetts Institute of Technology faculty who are primarily centered in the Massachusetts General Hospital Pathology department and Cancer Center. This interactive, overlapping community of scientists and physician- scientists is organized into thematic programs that include: cancer genetics; cancer epigenetics; animal models of cancer; RNA biology; tissue, cell, and genome engineering technologies; cell cycle control and DNA damage repair; stem cell biology; immunology and chemical biology; and in vivo imaging for cancer biology and diagnosis. As in previous cycles, the trainees will be selected from a highly competitive pool of MD, MD-PhD and PhD applicants on the basis of prior academic and research achievements and evidence of a strong commitment to a career in cancer biology. The period of training will be two or three years for each successful applicant. An active and program- specific recruitment and retention program to enhance diversity ensures that diverse applicants have access to, and will succeed in, the training program. In summary, the proposed T32 program renewal capitalizes on a highly interactive, experienced and focused faculty; a distinguished record of training productive physicians and scientists, including underrepresented minorities; state-of-the-art facilities and educational resources; and exposure of the trainees to basic and translational aspects of cancer biology.
    4 schema:endDate 2021-06-30T00:00:00Z
    5 schema:funder https://www.grid.ac/institutes/grid.48336.3a
    6 schema:identifier N0f190d2c5234491991518e1860a90eec
    7 N8b7be743fd884f3db7039a43afc01083
    8 schema:inLanguage en
    9 schema:keywords DNA damage repair
    10 Harvard
    11 MD
    12 MD-PhD
    13 MGH Pathology department
    14 Massachusetts General Hospital Pathology department
    15 Massachusetts Institute
    16 Molecular Immunology
    17 PhD applicants
    18 RNA biology
    19 T32 program renewal
    20 T32 training grant
    21 Technology Faculty
    22 access
    23 animal models
    24 applicants
    25 art facilities
    26 basis
    27 cancer
    28 cancer biology
    29 cancer center
    30 cancer epigenetics
    31 cancer genetics
    32 career
    33 cell cycle control
    34 cells
    35 chemical biology
    36 community
    37 competitive pool
    38 considerable number
    39 current proposals
    40 decades
    41 description
    42 diagnosis
    43 distinguished record
    44 diverse applicants
    45 diversity
    46 educational resources
    47 evidence
    48 exposure
    49 faculty positions
    50 five-year funding periods
    51 focused faculty
    52 genome engineering technologies
    53 high quality journals
    54 immunology
    55 industry
    56 medical school
    57 mentors
    58 other basic scientists
    59 paper
    60 pathologist-scientists
    61 period
    62 physician- scientists
    63 position
    64 prestigious universities
    65 previous cycle
    66 productive physicians
    67 program- specific recruitment
    68 research
    69 research achievements
    70 retention programs
    71 scientists
    72 state
    73 stem cell biology
    74 strong commitment
    75 successful applicants
    76 successful training
    77 summary
    78 thematic program
    79 tissue
    80 trainees
    81 training
    82 training program
    83 translational aspects
    84 tumor biology
    85 underrepresented minorities
    86 vivo imaging
    87 years
    88 schema:name Molecular Immunology and Tumor Biology
    89 schema:recipient Nf66d324470e34642bf596c3b27f530af
    90 sg:person.0667170477.75
    91 https://www.grid.ac/institutes/grid.32224.35
    92 schema:sameAs https://app.dimensions.ai/details/grant/grant.2682506
    93 schema:sdDatePublished 2019-03-07T12:07
    94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    95 schema:sdPublisher N6ed2f6ceddd44417b5f9423a4b9eda07
    96 schema:startDate 1978-09-30T00:00:00Z
    97 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=9512692
    98 sgo:license sg:explorer/license/
    99 sgo:sdDataset grants
    100 rdf:type schema:MonetaryGrant
    101 N0f190d2c5234491991518e1860a90eec schema:name dimensions_id
    102 schema:value 2682506
    103 rdf:type schema:PropertyValue
    104 N6ed2f6ceddd44417b5f9423a4b9eda07 schema:name Springer Nature - SN SciGraph project
    105 rdf:type schema:Organization
    106 N861e84ff7c7a41b9948798cddf3c4f89 schema:currency USD
    107 schema:value 6510216
    108 rdf:type schema:MonetaryAmount
    109 N8b7be743fd884f3db7039a43afc01083 schema:name nih_id
    110 schema:value T32CA009216
    111 rdf:type schema:PropertyValue
    112 Nf66d324470e34642bf596c3b27f530af schema:member sg:person.0667170477.75
    113 schema:roleName PI
    114 rdf:type schema:Role
    115 anzsrc-for:2206 schema:inDefinedTermSet anzsrc-for:
    116 rdf:type schema:DefinedTerm
    117 sg:person.0667170477.75 schema:affiliation https://www.grid.ac/institutes/grid.32224.35
    118 schema:familyName JOUNG
    119 schema:givenName J. KEITH
    120 rdf:type schema:Person
    121 https://www.grid.ac/institutes/grid.32224.35 schema:name MASSACHUSETTS GENERAL HOSPITAL
    122 rdf:type schema:Organization
    123 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...